Le Lézard
Classified in: Health
Subject: RCL

Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements


WASHINGTON, Aug. 29, 2019 /PRNewswire/ -- https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements 

The U.S. Consumer Product Safety Commission is an independent federal agency created by Congress in 1973 and charged with protecting the American public from unreasonable risks of serious injury or death from more than 15,000 types of consumer products under the agency's jurisdiction. To report a dangerous product or a product-related injury, call the CPSC hotline at 1-800-638-2772, or visit http://www.saferproducts.gov. Further recall information is available at http://www.cpsc.gov. (PRNewsfoto/U.S. Consumer Product Safety Co)

Recall Summary

Name of Product: Losartan Potassium and Ezetimibe prescription drug bottles

Hazard: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

Remedy: Replace

Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.

Consumer Contact: 
Sandoz at 800-525-8747 from 8:30 a.m. to 5 p.m. ET Monday to Friday or online at www.us.sandoz.com and click on "Patients and Customers" then "Product Safety Notices."

Recall Details

Units: About 636,000

Description:
This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers.  The recalled bottles have "Sandoz," the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels.  The recall includes the following:

Recalled Prescription
Drugs

NDC
Numbers

Lot
Numbers

Expiration Date

Ezetimibe 10mg Tablets

0781-5690-31

JE4491

Aug-2020

30 count bottle


JE4492

Aug-2020



JE4493

Aug-2020



JE4495

Aug-2020



JG0308

Sep-2020



JG0310

Sep-2020



JG0311

Sep-2020



JG0312

Sep-2020



JG5061

Sep-2020



JG5063

Sep-2020



JK8921

Oct-2020



JK8922

Oct-2020



JK8923

Oct-2020



JK8924

Oct-2020



JL5535

Oct-2020



JM2253

Oct-2020



JM2254

Oct-2020



JM2255

Oct-2020



JM2257

Oct-2020



JM2258

Oct-2020



JM2259

Oct-2020



JM5986

Oct-2020



JM5987

Oct-2020

Ezetimibe 10mg Tablets

0781-5690-92

JE4481

Aug-2020

90 count bottle


JG0249

Sep-2020



JK8989

Oct-2020



JN0764

Jan-2021

Losartan Potassium 50mg Tablets

0781-5701-31

HV9471

Feb-2020

30 count bottle




Incidents/Injuries: None Reported

Sold At: Clinics and pharmacies nationwide as a prescribed medicine from July 2018 through August 2019.  The container was included in the price of the medication, which varied based on quantities prescribed, health insurance terms and other factors.

Distributor: Sandoz Inc., of Princeton, N.J.  

Manufactured in: Slovenia

About U.S. CPSC:
The U.S. Consumer Product Safety Commission is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products under the agency's jurisdiction.  Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually. CPSC is committed to protecting consumers and families from products that pose a fire, electrical, chemical or mechanical hazard. CPSC's work to ensure the safety of consumer products - such as toys, cribs, power tools, cigarette lighters and household chemicals ? contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years.

Federal law bars any person from selling products subject to a publicly-announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.

For more lifesaving information, follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC or sign up to receive our e-mail alerts. To report a dangerous product or a product-related injury go online to www.SaferProducts.gov or call CPSC's Hotline at 800-638-2772 or teletypewriter at 301-595-7054 for the hearing impaired.

CPSC Consumer Information Hotline
Contact us at this toll-free number if you have questions about a recall:
800-638-2772 (TTY 301-595-7054)
Times: 8 a.m. ? 5:30 p.m. ET; Messages can be left anytime
Call to get product safety and other agency information and to report unsafe products.

Media Contact
Please use the phone numbers below for all media requests.
Phone: 301-504-7908
Spanish: 301-504-7800

Recall Number: 19-194

SOURCE U.S. Consumer Product Safety Commission


These press releases may also interest you

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...

at 09:05
Adolescence isn't just a phase; it's a time of unparalleled growth and an opportunity for developing strengths that will influence our adult lives. Recognizing the potential of this developmental stage, Committee for Children a global nonprofit and...

at 09:00
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...

at 09:00
LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies,...



News published on and distributed by: